Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus (T2DM) is a chronic metabolic disorder characterized by persistent hyperglycemia resulting from a progressive insulin secretory defect on a background of insulin resistance. It is the most common form of diabetes, accounting for over 90% of cases worldwide.

T2DM is caused by a complex interaction between genetic predisposition and environmental factors. Key factors include:

• Genetics: Polygenic inheritance patterns.


• Obesity: Strongly linked to visceral adiposity.


• Lifestyle: Sedentary behavior and high-calorie diets.


• Aging: Progressive decline in pancreatic beta-cell function.

The primary mechanism involves peripheral insulin resistance in skeletal muscle, adipose tissue, and the liver, combined with progressive beta-cell dysfunction.

1. Insulin Resistance: Target tissues fail to respond adequately to insulin, reducing glucose uptake.


2. Hepatic Glucose Production: Increased gluconeogenesis and glycogenolysis due to hepatic insulin resistance.


3. Beta-cell Dysfunction: Compensatory hyperinsulinemia eventually fails, leading to beta-cell exhaustion and progressive loss of insulin secretion.


4. Incretin Defect: Diminished secretion and action of GLP-1 and GIP.


5. Renal Absorption: Upregulation of SGLT2 channels increases glucose reabsorption in the kidneys.

• Prevalence: Affects approximately 10.5% of the global adult population.
• Age: Most commonly diagnosed in adults aged 45–64, though pediatric cases are rising.
• Gender: Slightly higher prevalence in males than females.
• Ethnicity: Higher rates in Hispanic, Black, Native American, and Asian populations.

• BMI ≥ 25 kg/m² (or ≥ 23 kg/m² in Asian-Americans)
• Physical inactivity
• First-degree relative with T2DM
• History of gestational diabetes or delivering a baby > 9 lbs
• Hypertension (≥ 130/80 mmHg) or dyslipidemia (HDL < 35 mg/dL, TG > 250 mg/dL)
• Polycystic Ovary Syndrome (PCOS)

• Vitals: Elevated blood pressure (hypertension is highly co-morbid).
• Inspection: Acanthosis nigricans (hyperpigmented, velvety skin patches on the neck/axillae), skin tags, central adiposity, dry skin.
• Palpation: Decreased sensation to a 10g monofilament on the plantar foot surfaces, diminished pedal pulses.
• Auscultation: Carotid or femoral bruits indicating atherosclerotic disease.

• A. Clinical Assessment: Comprehensive evaluation of cardiovascular and neuropathic risk factors.
• B. Laboratory Testing: FPG, HbA1c, OGTT, Lipid Panel, Serum Creatinine with eGFR, Urine Albumin-to-Creatinine Ratio (UACR).
• C. Imaging Studies: Routine screening for complications (e.g., Fundus Photography for retinopathy).
• D. Functional Tests: 10g monofilament and vibration sensation testing.
• E. Biopsy Findings: Not indicated for routine clinical diagnosis.
• F. Genetic Testing: Reserved for suspected monogenic diabetes (MODY).
• G. Differential Diagnosis: Type 1 Diabetes Mellitus, LADA, gestational diabetes, drug-induced hyperglycemia.

• Fundus Photography: Used for annual screening to detect early stages of diabetic retinopathy (e.g., microaneurysms, hard exudates).
• Duplex Ultrasonography: Indicated for patients with suspected peripheral arterial disease presenting with claudication or non-healing ulcers.

• Type 1 Diabetes Mellitus (T1DM): Differentiated by acute onset, presence of islet autoantibodies (e.g., GAD65), and absolute insulin deficiency (low C-peptide).
• Latent Autoimmune Diabetes in Adults (LADA): Features slower onset than T1DM but tests positive for islet autoantibodies.

• Microvascular: Diabetic retinopathy (blindness), diabetic nephropathy (end-stage renal disease), and peripheral neuropathy.
• Macrovascular: Coronary artery disease (myocardial infarction), cerebrovascular disease (ischemic stroke), and peripheral arterial disease.
• Other: Diabetic foot ulcers leading to lower-limb amputations.

Long-term prognosis depends heavily on glycemic control and the mitigation of cardiovascular risk factors. Early, intensive management can slow or halt the progression of micro- and macrovascular complications, enabling a normal lifespan.

• Primary: Weight management, healthy diet, and regular physical activity.
• Secondary: Screening adults aged 35–70 who are overweight or obese every 3 years.

The following homeopathic remedies have been historically indicated for symptoms associated with Type 2 Diabetes Mellitus. Selection should be based on individualized symptom totality and constitutional assessment.

• Homeopathy by Hadhrat Mirza Tahir Ahmad (r.a.) — Primary clinical reference
• Robin Murphy — Lotus Materia Medica (3rd Edition)
• William Boericke — Pocket Manual of Homœopathic Materia Medica & Repertory
• ICD-10/ICD-11 Classification — World Health Organization
• Harrison's Principles of Internal Medicine (Reference Standard)

This clinical reference profile is compiled from authoritative medical sources for educational purposes. Always verify clinical data with current medical guidelines.

📊 Advanced Diabetes & Metabolic Analyzer

Comprehensive metabolic assessment: converts blood sugar units (mg/dL ↔ mmol/L), estimates average glucose (eAG) from HbA1c, calculates HOMA-IR for insulin resistance, and evaluates overall Type 2 Diabetes risk.